MedTrace Logo

SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs

NCT04710563 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 458

Last updated 2025-10-20

No results posted yet for this study

Summary

A research project capturing experiences of patients with critical limb threatening ischemia, with the ultimate goal of setting new standards for diagnosing, describing detailed patient-centered outcomes, and evaluating the variability in therapeutic approaches and their association with outcomes.

Conditions

  • Peripheral Arterial Disease

Sponsors & Collaborators

  • University of Chicago

    collaborator OTHER

  • Oregon Health and Science University

    collaborator OTHER

  • University of California, Davis

    collaborator OTHER

  • University of Southern California

    collaborator OTHER

  • Baylor College of Medicine

    collaborator OTHER

  • The Cleveland Clinic

    collaborator OTHER

  • Emory University

    collaborator OTHER

  • Brown University

    collaborator OTHER

  • Columbia University

    collaborator OTHER

  • University of Minnesota

    collaborator OTHER

  • Saint Luke's Health System

    collaborator OTHER

  • Abbott

    collaborator INDUSTRY

  • Janssen Scientific Affairs, LLC

    collaborator INDUSTRY

  • Yale University

    lead OTHER

Principal Investigators

  • Kim Smolderen, PhD · Yale University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-11
Primary Completion
2024-12-31
Completion
2028-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04710563 on ClinicalTrials.gov